Raphoe Management
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM AUSTRALIA, CANADA,
JAPAN OR THE UNITED STATES
Raphoe Management Limited ("Raphoe")
Statement in relation to Rentokil Initial plc ("Rentokil")
On 17th October, 2005, Raphoe announced it was continuing discussions with
Rentokil shareholders against a background of having agreed to the principle of
a framework of performance criteria to be met in order for the financial
arrangements set out in its statement of 8th September to apply.
These discussions have continued until this morning, but have regrettably not
resulted in an agreement being reached that was satisfactory to the parties
involved. Accordingly they have been terminated.
Sir Gerry Robinson said, "I am sorry that we have not found the right way
forward. This was a genuine attempt to make a change with the existing
shareholders staying involved. This has been an unsettling time for employees of
Rentokil Initial and I apologise for that. I wish them and Doug Flynn every
success for the future."
Contacts:
Sir Gerry Robinson
c/o Cubitt Consulting 020 7367 5100
Europa Partners Limited:
David von Simson 020 7661 9338
Cubitt Consulting:
Simon Brocklebank-Fowler 020 7367 5100
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.